The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 102.00
Ask: 105.00
Change: -0.50 (-0.48%)
Spread: 3.00 (2.941%)
Open: 104.00
High: 104.00
Low: 103.50
Prev. Close: 104.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director and PDMR Share Option Awards

10 Nov 2014 09:28

RNS Number : 5752W
Intercede Group PLC
10 November 2014
 



10 November 2014

Intercede Group plc

("the Company" or "the Group")

Director and PDMR Share Option Awards

 

On 7 November 2014, new share options were granted under the existing Intercede Group plc Long Term Incentive Plan to Executive Directors, a Person Discharging Managerial Responsibilities (PDMR) and senior managers of the Group.

The award is in accordance with the resolution that was approved by shareholders at the Company's AGM on 17 September 2014:

a) option exercise price of 127.5p representing the mid-market price as at close of play on 6 November 2014;

b) performance condition for the option to become exercisable being that the share price of the Company reaches or exceeds 400p for a period of 30 consecutive days over the period commencing on the third anniversary of the date of grant and ending on the seventh anniversary of the date of grant. In the event of a takeover of the Company, options would only vest if the offer price per share was at least 200p; and

c) the total number of share options granted was 500,000 which includes the following award levels to the executive directors and PDMR:

 

Name

Number of Share Options

 

Richard Parris

200,000

Andrew Walker

50,000

Jayne Murphy

50,000

 

Following the options granted above, the interests of the Directors and their immediate families in the total voting rights of the Company are detailed below:

 

 

 

Number of Ordinary Shares

 

Percentage of Voting Rights

(%)

Total Number of Shares under Option

 

 

 

Richard Parris

 5,645,396

11.6

 1,119,565

Andrew Walker

 1,497,192

3.1

424,094

 

 

 

 

 

Enquiries:

 

Intercede Group plc Tel: 01455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Ltd Tel: 020 7220 0500

Stuart Andrews, Corporate Finance

Joanna Weaving, Corporate Broking

 

 

About Intercede

 

Intercede is a software company specialising in identity and credential management with a global team of experts located in the US and UK.

 

Intercede's MyID software enables organisations to create and use trusted digital identities for employees, citizens and machines. This allows secure access to services, facilities, information and networks.

 

MyID meets the highest government standards yet is simple enough to be deployed onto consumer devices such as smart phones and tablets. Critically, MyID provides an easy, convenient and secure alternative to passwords.

 

Millions of identities are managed using MyID and Intercede has provided identity verification and management services to global customers for more than 20 years. MyID is a commercial off the shelf software product, designed and developed to be configurable so it can be embedded as the cornerstone of cyber security infrastructure for governments and corporations.

 

Customers trusting Intercede for secure digital identity include the US and UK governments and some of the world's largest corporations, telecommunications providers and information technology partners.

 

For more information visit www.intercede.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGCBDBIDBBGSG
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.